BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, June 5, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 15, 2021
View Archived Issues
aTyr Pharma initiates new discovery programs from its tRNA synthetase platform
Read More
Incyte begins phase II study with retifanlimab in advanced or metastatic endometrial cancer
Read More
New phase I/II study evaluates hLB-001 in pediatric patients with severe methylmalonic acidemia
Read More
Promising preclinical data for SIG-005 encapsulated nonviral cell-based therapy for MPS
Read More
Phase III studies show superiority of topical tirbanibulin to vehicle in actinic keratosis
Read More
Nonhuman primate models of COVID-19 through airborne exposure to SARS-CoV-2
Read More
A humanized mouse model of Pneumocystis pneumonia to better understand the human immune response
Read More
Tocilizumab in addition to steroids shows benefit in patients hospitalized with COVID-19
Read More
Reata Pharmaceuticals identifies new nitric oxide production inhibitors
Read More
Heat shock or hypoxia triggers amyloids, translation in nucleus
Read More
FDA approves Cosela for myeloprotection in patients with extensive-stage SCLC receiving chemotherapy
Read More
TMEM16A calcium-activated chloride channel as a novel therapeutic target against HRSV
Read More
REG3A unveiled as a risk marker for gastrointestinal chronic GvHD
Read More
Roche presents phase III data for faricimab in patients with DME and nAMD
Read More
Phase I/II data presented for Trappsol Cyclo in patients with NPC1
Read More
Panzyga approved in U.S. for chronic inflammatory demyelinating polyneuropathy
Read More
RBD-SpyVLP COVID-19 vaccine shows promise in preclinical studies
Read More
Phase II study evaluates E-52862 in early treatment of outpatients with mild COVID-19 symptoms
Read More
New phase II trial investigates ChAdOx1 nCoV-19 coronavirus vaccine in children
Read More
